Patent · US Active

Process for preparing Imatinib

US7507821B2 · kind B2 · utility

8Cited by

1References

5Claims

0Family size

Assignee

Chemagis Ltd. · IL

Inventors

Huang Anli · Shanghai, CN
Liu Xing · Shanghai, CN
Lior Zelikovitch · Mazkeret Batya, IL
Joseph Kaspi · Givatayim, IL

Key dates

Filing date	Dec 28, 2005
Grant date	Mar 24, 2009
Priority date	—
Expiry date	Nov 24, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A novel process is disclosed for producing Imatinib, using the precursor 2-chloro-4-(3-pyridyl)-pyrimidine, thus improving Imatinib preparation via an alternative synthetic route, avoiding the use of the toxic reagent cyanamide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.